Latest news with #Anyang
GMA Network
2 days ago
- Sport
- GMA Network
Javi Gomez de Liaño, Ian Miller join Strong Group in Jones Cup
Javi Gomez de Liaño and Ian Miller have been tapped to join Strong Group Athletics' title defense bid in the 2025 William Jones Cup set from July 12 to 20 at the Xinzhuang Gymnasium in New Taipei City, Taiwan. The two additions will join a stacked lineup headlined by local stars Kiefer Ravena, Rhenz Abando, Jason Brickman, Dave Ildefonso, Ange Kouame, Geo Chiu, and reigning NCAA MVP Allen Liwag. 'These are excellent additions to our team,' said head coach Charles Tiu. 'Javi and Ian bring high-level experience and versatility. They'll really complement the core group we already have.' The 26-year-old Gomez de Liaño is heading into his second year with Korean club Anyang. He posted averages of 8.4 points and 2.7 rebounds in his debut campaign. American reinforcement Miller, meanwhile, saw action in the Basketball Champions League Asia and was named the MVP in the Asia-East division after averaging 17.9 points on 44.1% shooting, alongside 2.6 rebounds and 5.6 assists. 'He's coming off an impressive run in BCL Asia, so we're excited to bring that firepower to our backcourt,' said Tiu. SGA will kick off its campaign for back-to-back championships on July 13 against Chinese-Taipei A, followed by matchups against Japan's Under-25 team, Qatar, Australia, Chinese-Taipei B, Malaysia, Bahrain, and UAE. —Bea Micaller/JMB, GMA Integrated News
Yahoo
23-06-2025
- Health
- Yahoo
NEL Animal Cardiovascular Center Achieves World's First Surgical Correction of Complex VSD in Canine Patient
ANYANG, South Korea, June 23, 2025--(BUSINESS WIRE)--NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world's first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This veterinary milestone is highly significant, as it marks the first such case not only in Korea but also globally, with no previous reports of successful surgical treatment for complex VSDs. The patient was diagnosed with a unique form of VSD—a single, continuous defect extending from the perimembranous to the subarterial region (Perimembranous VSD extending into subarterial region). Given that there had been no prior successful surgical cases even for typical VSDs in veterinary medicine, this breakthrough greatly expands the possibilities for surgical treatment of congenital heart disease in Korea's veterinary cardiac surgery field. Over the past year, NEL's cardiac surgery team has gained experience through more than 50 open-heart surgeries using cardiopulmonary bypass. Based on this expertise, the team developed a thorough surgical plan. During the procedure, the complex VSD involving both membranous and subarterial regions was confirmed. The team performed incisions in the right atrium and pulmonary artery, successfully closing the defect with a bovine pericardial patch. Immediately after surgery, the left-to-right shunt was completely resolved, and the risk of progressive regurgitation due to aortic valve prolapse was eliminated. The patient's cardiac function recovered to near-normal levels, and the long-term prognosis is considered highly favorable. Subarterial VSDs are particularly dangerous due to the risk of aortic valve prolapse and severe regurgitation, making early surgical intervention crucial. The success of this surgery offers new hope for animals with congenital heart defects, demonstrating the potential for a surgical cure. Dr. Tae-Heum Um, Director of NEL Animal Cardiovascular Center, stated, "Although this was a complex defect, thorough discussion and preparation among our medical team led to a successful outcome. We will continue our efforts so that more animals with congenital heart disease can lead healthy and normal lives." NEL Animal Cardiovascular Center is preparing an academic analysis and official report on this case, and sincerely hopes that this achievement contributes to the advancement of veterinary cardiac surgery not only in Korea, but also across Asia. View source version on Contacts NEL Animal Cardiovascular CenterYoon il-yong+82-31-421-7579heart@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
23-06-2025
- Health
- Associated Press
NEL Animal Cardiovascular Center Achieves World's First Surgical Correction of Complex VSD in Canine Patient
ANYANG, South Korea--(BUSINESS WIRE)--Jun 22, 2025-- NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world's first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This press release features multimedia. View the full release here: NEL Animal Cardiovascular Center's medical staff performing surgical correction of a complex ventricular septal defect (VSD) in a canine patient (Photo: NEL Animal Cardiovascular Center) This veterinary milestone is highly significant, as it marks the first such case not only in Korea but also globally, with no previous reports of successful surgical treatment for complex VSDs. The patient was diagnosed with a unique form of VSD—a single, continuous defect extending from the perimembranous to the subarterial region (Perimembranous VSD extending into subarterial region). Given that there had been no prior successful surgical cases even for typical VSDs in veterinary medicine, this breakthrough greatly expands the possibilities for surgical treatment of congenital heart disease in Korea's veterinary cardiac surgery field. Over the past year, NEL's cardiac surgery team has gained experience through more than 50 open-heart surgeries using cardiopulmonary bypass. Based on this expertise, the team developed a thorough surgical plan. During the procedure, the complex VSD involving both membranous and subarterial regions was confirmed. The team performed incisions in the right atrium and pulmonary artery, successfully closing the defect with a bovine pericardial patch. Immediately after surgery, the left-to-right shunt was completely resolved, and the risk of progressive regurgitation due to aortic valve prolapse was eliminated. The patient's cardiac function recovered to near-normal levels, and the long-term prognosis is considered highly favorable. Subarterial VSDs are particularly dangerous due to the risk of aortic valve prolapse and severe regurgitation, making early surgical intervention crucial. The success of this surgery offers new hope for animals with congenital heart defects, demonstrating the potential for a surgical cure. Dr. Tae-Heum Um, Director of NEL Animal Cardiovascular Center, stated, 'Although this was a complex defect, thorough discussion and preparation among our medical team led to a successful outcome. We will continue our efforts so that more animals with congenital heart disease can lead healthy and normal lives.' NEL Animal Cardiovascular Center is preparing an academic analysis and official report on this case, and sincerely hopes that this achievement contributes to the advancement of veterinary cardiac surgery not only in Korea, but also across Asia. View source version on CONTACT: NEL Animal Cardiovascular Center Yoon il-yong +82-31-421-7579 [email protected] KEYWORD: ASIA PACIFIC SOUTH KOREA INDUSTRY KEYWORD: CARDIOLOGY VETERINARY BIOTECHNOLOGY PETS SURGERY HEALTH HEALTH TECHNOLOGY CONSUMER SOURCE: NEL Animal Cardiovascular Center Copyright Business Wire 2025. PUB: 06/22/2025 08:00 PM/DISC: 06/22/2025 07:59 PM
Yahoo
23-06-2025
- Health
- Yahoo
NEL Animal Cardiovascular Center Achieves World's First Surgical Correction of Complex VSD in Canine Patient
ANYANG, South Korea, June 23, 2025--(BUSINESS WIRE)--NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world's first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This veterinary milestone is highly significant, as it marks the first such case not only in Korea but also globally, with no previous reports of successful surgical treatment for complex VSDs. The patient was diagnosed with a unique form of VSD—a single, continuous defect extending from the perimembranous to the subarterial region (Perimembranous VSD extending into subarterial region). Given that there had been no prior successful surgical cases even for typical VSDs in veterinary medicine, this breakthrough greatly expands the possibilities for surgical treatment of congenital heart disease in Korea's veterinary cardiac surgery field. Over the past year, NEL's cardiac surgery team has gained experience through more than 50 open-heart surgeries using cardiopulmonary bypass. Based on this expertise, the team developed a thorough surgical plan. During the procedure, the complex VSD involving both membranous and subarterial regions was confirmed. The team performed incisions in the right atrium and pulmonary artery, successfully closing the defect with a bovine pericardial patch. Immediately after surgery, the left-to-right shunt was completely resolved, and the risk of progressive regurgitation due to aortic valve prolapse was eliminated. The patient's cardiac function recovered to near-normal levels, and the long-term prognosis is considered highly favorable. Subarterial VSDs are particularly dangerous due to the risk of aortic valve prolapse and severe regurgitation, making early surgical intervention crucial. The success of this surgery offers new hope for animals with congenital heart defects, demonstrating the potential for a surgical cure. Dr. Tae-Heum Um, Director of NEL Animal Cardiovascular Center, stated, "Although this was a complex defect, thorough discussion and preparation among our medical team led to a successful outcome. We will continue our efforts so that more animals with congenital heart disease can lead healthy and normal lives." NEL Animal Cardiovascular Center is preparing an academic analysis and official report on this case, and sincerely hopes that this achievement contributes to the advancement of veterinary cardiac surgery not only in Korea, but also across Asia. View source version on Contacts NEL Animal Cardiovascular CenterYoon il-yong+82-31-421-7579heart@
Yahoo
18-06-2025
- Automotive
- Yahoo
Vieworks to Unveil Dual Imaging TDI Camera at automatica 2025
ANYANG, South Korea, June 18, 2025 /PRNewswire/ -- Vieworks, a global leader in machine vision solutions, will unveil its latest advancements in machine vision technology at automatica 2025, held in Munich, Germany, from June 24 to 27 (Hall B5, Booth 506). Vieworks will showcase its expanded portfolio of industrial cameras and lenses, with a spotlight on the newly launched dual imaging VTD Series. At the trade fair, Vieworks will present its full range of area scan cameras, offering resolutions from 0.4 megapixels to an industry-leading 1152 megapixels. Among the highlights is the compact and versatile VZ Series, featuring GigE, 2.5GigE, and USB 3.0 interfaces. These cameras are ideal for automated inspection systems across industries. Vieworks' TDI (time delayed integration) line scan cameras are renowned for their exceptional sensitivity, achieved through up to 256 stages of integration. Available in M42, M58, M72, and M95 mounts from 2k to 23k resolution, these TDI line scan cameras are suitable for various applications in low-light environments. Making its official debut at the show, the VTD-16K5X2 camera captures two images in a single scan through dual imaging technology. This innovation eliminates the need for separate cameras or multiple scans—reducing cycle time and operational costs. Also featured will be the VT Sense Series, equipped with BSI (back-side illuminated) sensors for enhanced sensitivity. These high-end TDI cameras boast exceptional sensitivity as well as superior quantum efficiency (QE) and signal-to-noise ratio (SNR). The back-side illuminated VT Sense ensures superior image quality in visible, ultraviolet (UV), and near-infrared (NIR) spectrums. In addition to its camera lineup, Vieworks will also present the VEO Series, a family of industrial lenses codeveloped with Schneider Kreuznach. These lenses are optimized to fully leverage the capabilities of Vieworks' high-resolution cameras. "We're excited to introduce our latest innovations, including the VTD-16K5X2, at automatica 2025," a Vieworks spokesperson remarked. "The event is a key opportunity to engage with our partners and customers across Europe and demonstrate how our technologies are driving the future of automation." As Europe's leading automation trade fair, automatica 2025 is expected to attract a record number of exhibitors and attendees. About Vieworks Co., Ltd. Vieworks is a leading provider of machine vision technologies, offering a comprehensive range of industrial cameras, lenses, and vision system accessories. Committed to innovation and excellence, Vieworks is your trusted partner in delivering machine vision solutions. For more information, please visit View original content to download multimedia: SOURCE Vieworks Co., Ltd.
